Fundraising FoxBoundary Capital — 2021 Investments
1 investments dated 2021 · listed companies and verified rows first · show all
Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
Deep TechDigital HealthHealthtechMedical Devices
Andrew Round(Chief Executive Officer (ad interim))Dr. Päivi Maria Paldánius(Chief Medical Officer & Chief Operating Officer)Sebastien Cuvelier Mussalian(Chief Technology Officer)Dr. Phil Taday(Head of R&D)Paul Jesson(Chief Finance Officer)
Co-investorsAnglia Capital GroupDeepbridge Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.